Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.070
+0.080 (4.02%)
At close: Mar 12, 2026, 4:00 PM EDT
2.055
-0.015 (-0.71%)
After-hours: Mar 12, 2026, 7:55 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $126.05 million as of March 12, 2026. Its market cap has increased by 352.80% in one year.
Market Cap
126.05M
Enterprise Value
93.67M
1-Year Change
352.80%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $126.05M, a decrease of -46.26%. That is a compound annual growth rate of -8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 121.18M | 28.39% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 128.78M |
| Alpha Cognition | 128.06M |
| Aardvark Therapeutics | 126.07M |
| Genelux | 124.00M |
| Inovio Pharmaceuticals | 118.86M |
| Gossamer Bio | 117.37M |
| Cassava Sciences | 114.97M |
| Coya Therapeutics | 114.89M |